Moderna

Moderna ($MRNA) stock surged 130% following reports that a cancer vaccine showed signs of preventing melanoma from spreading.

Moderna $MRNA surges 130%

Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.

Moderna skin cancer vaccine results

Three days ago someone said AI will cure cancer. Today an AI built personalized cancer vaccine passed a Phase 3 trial. Moderna and Merck sequence tumor DNA vs healthy DNA, use AI to pick mutations most likely to spark a… Afficher plus

AI melanoma vaccine Phase 3 results

Moderna's mRNA flu vaccine just got a big boost. An independent FDA advisory panel unanimously recommended it for approval in older adults. The vaccine showed about 27% better efficacy than standard flu shots in clinical… Afficher plus

Moderna mRNA flu vaccine FDA panel